LEADING IN MEDICAL BREAKTHROUGHS
LEADING IN MEDICAL BREAKTHROUGHS

“INNOVATION, BREAKTHROUGH , QUALITY OF LIFE FOR HEALTH”

News
GoldenBiotech Antroquinonol Phase 2 NSCLC Clinical Study Presents Brilliant Results in ASCO Meeting.
Read More "News"
R&D Pipeline
We believe, expect and pioneer… “ Based on our ultimate spirit, GBC develops new drug candidates through our solid footstone and promotes health by promising...
Read More "R&D Pipeline"
PHARMACEUTICAL
Information Regarding Expanded Access & Right to Try When a patient does not respond to current approved treatments for a variety of reasons, other options...
Read More "PHARMACEUTICAL"

Golden Biotechnology Corporation (GBC), founded by Mr. Sheng Yung, Liu in 2002, is an leading and innovative drug discovery and evidence-based healthy food supplement manufacturing company dedicated to enhancing lives by developing high quality products that prevent and treat diseases.

GBC’s main focus is on new drug R&D, IP right, pharmacology, toxicology and clinical studies. GBC also has successfully built up the screening platforms to identify bioactive compounds from traditional Chinese herbal medicine that includes more than 480 kinds of local plants, 1300 species of fungi, mushrooms and seaweeds.

Throughout 2002-2005, around 400 drug candidates were obtained from these screening platforms. Based on our own core chemical database, the ubiquinone-like structure of Antroquinonol® was actually discovered in 2006 during drug development. The pharmacology and toxicology of Antroquinonol® have been established along with the CMC (Chemistry, Manufacturing, and Controls) development and large-scale cGMP manufacturing of Antroquinonol®.